Ventricular and Pulmonary Vascular Reserve after the Fontan Operation
Fontan 手术后心室和肺血管储备
基本信息
- 批准号:10133126
- 负责人:
- 金额:$ 17.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-04-01 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultArrhythmiaAwardBloodBlood CirculationBlood VesselsBlood flowBypassCardiac Catheterization ProceduresCardiopulmonaryCardiovascular PhysiologyCaringCatheterizationCentral venous pressureChronicChronic Kidney FailureCirrhosisClinicClinicalClinical InvestigatorCommon VentricleComplexCongestiveDataDeteriorationDiagnosticDiseaseDisease ProgressionEarly identificationEchocardiographyExerciseExercise PhysiologyExercise TestExposure toFailureFontan ProcedureFunctional disorderGoalsGoldGrantHealth Care CostsHealthcareHeart failureHemodynamic ProcessesHypertensionInterventionKnowledgeLeadLife ExpectancyLiteratureLow Cardiac OutputLungMentorsMentorshipMethodologyMethodsMorbidity - disease rateNatural HistoryNorth AmericaOrganOutcomeOutcome MeasurePatient CarePatient Outcomes AssessmentsPatient RecruitmentsPatientsPhysiologyPopulationPrevalencePrevention strategyProtein-Losing EnteropathiesPublic HealthPulmonary CirculationResearchResearch DesignResearch PersonnelResourcesRestRisk ManagementRoleSideStressSupinationThromboembolismTimeVascular DiseasesVenousVentricularWorkcareercohortcomorbiditycongenital heart disorderelectric impedanceexperiencefollow-uphemodynamicsimprovedinnovationmortalitynoveloperationpalliationpressurepreventprogramsresponserisk stratificationskillssymptom managementtooltreatment strategy
项目摘要
PROJECT SUMMARY
CANDIDATE: Dr. Egbe's long-term goal is to become an independent clinical investigator in the field of adult
congenital heart disease. His short-term goal is to study new and unexplored aspects of hemodynamics and
clinical outcomes in people with Fontan palliation. To achieve these goals, Dr. Egbe plans to: (1) Acquire
expertise in advanced statistical methodology, exercise physiology and hemodynamics, and management of
circulatory failure in people with Fontan physiology; (2) Develop new collaborative relationships with other
researchers; (3) Submit RO1 proposals during the 3rd and 5th years of the award.
ENVIRONMENT: The Mayo Clinic is a world-renowned center for innovation and research, and the Adult
Congenital Heart Disease program at Mayo Clinic cares for the largest cohort of Fontan patients in North
America, making it ideal for patient recruitment for the proposed studies. Dr. Borlaug, the primary mentor for
this grant, is an expert in exercise hemodynamics and cardiovascular physiology, and has a track record of
successful mentorship.
RESEARCH
Background: Patients with Fontan palliation have significantly reduced long-term survival because of Fontan
associated diseases (FAD). Available data suggest that FAD are downstream complications of chronic venous
congestion, but there is paucity of data about the upstream hemodynamic processes, such as pulmonary
vascular disease (PVD) and ventricular diastolic dysfunction (VDD), responsible for chronic venous congestion
and FAD. We will address these gaps in knowledge through the proposed studies.
Specific Aims: We will determine the prevalence of PVD and VDD in patients with Fontan physiology using
invasive and noninvasive hemodynamic cardiopulmonary exercise testing (Aims #1 and #2), and then evaluate
the impact of rest-exercise PVD and VDD on clinical outcomes (Aim #3).
Study Design and Outcome Measures: The studies will be conducted on adult Fontan patients undergoing
cardiac catheterization for clinical indications at Mayo Clinic Rochester, MN. Simultaneous cardiac
catheterization and echocardiography will be performed at rest and during exercise (Aims #1 and #2), and the
occurrence of rest-exercise PVD and VDD will be correlated with clinical outcomes during follow-up (Aim#3).
Potential Public Health Contribution: Identifying and treating the early stages of PVD and VDD will
potentially prevent or at least deter FAD, improve survival and reduce healthcare cost in this population.
Relationship to the Career Goals of the Candidate: The data and skill set acquired during these projects will
form the basis for an RO1 application focused on modifying the natural history of FAD, a critical step towards
becoming an independent clinical investigator in this field.
项目概要
候选人:Egbe博士的长期目标是成为成人领域的独立临床研究者
先天性心脏病。他的短期目标是研究血流动力学和未探索的新方面
Fontan 姑息治疗患者的临床结果。为了实现这些目标,Egbe 博士计划:(1) 收购
先进统计方法、运动生理学和血流动力学以及管理方面的专业知识
患有 Fontan 生理学的人会出现循环衰竭; (2) 与他人建立新的合作关系
研究人员; (3)在奖项第3年和第5年期间提交RO1提案。
环境:梅奥诊所是世界著名的创新和研究中心,成人
梅奥诊所的先天性心脏病项目为北部最大的 Fontan 患者群体提供护理
美国,使其成为拟议研究的患者招募的理想选择。 Borlaug 博士,主要导师
此项资助是运动血流动力学和心血管生理学方面的专家,并且拥有以下记录:
成功的指导。
研究
背景:由于 Fontan 姑息治疗,患者的长期生存率显着降低
相关疾病(FAD)。现有数据表明 FAD 是慢性静脉血栓的下游并发症
充血,但缺乏有关上游血流动力学过程的数据,例如肺
血管疾病(PVD)和心室舒张功能障碍(VDD),导致慢性静脉充血
和FAD。我们将通过拟议的研究来解决这些知识差距。
具体目标:我们将使用 Fontan 生理学方法确定 PVD 和 VDD 患者的患病率
有创和无创血流动力学心肺运动测试(目标#1和#2),然后评估
休息运动 PVD 和 VDD 对临床结果的影响(目标#3)。
研究设计和结果衡量:该研究将对接受 Fontan 治疗的成年患者进行
明尼苏达州罗彻斯特梅奥诊所的临床适应症心导管插入术。同时心脏
导管插入术和超声心动图检查将在休息和运动期间进行(目标#1和#2),并且
休息运动 PVD 和 VDD 的发生将与随访期间的临床结果相关(目标#3)。
潜在的公共卫生贡献:识别和治疗早期阶段的 PVD 和 VDD 将
可能预防或至少阻止 FAD、提高该人群的生存率并降低医疗费用。
与候选人职业目标的关系:在这些项目中获得的数据和技能将
形成 RO1 应用的基础,重点是改变 FAD 的自然历史,这是迈向的关键一步
成为该领域的独立临床研究者。
项目成果
期刊论文数量(60)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Long-Term Outcomes in Patients With Turner Syndrome: A 68-Year Follow-Up.
特纳综合征患者的长期结果:68 年随访。
- DOI:
- 发表时间:2019
- 期刊:
- 影响因子:5.4
- 作者:Fuchs, Margaret M;Attenhofer Jost, Christine;Babovic;Connolly, Heidi M;Egbe, Alexander
- 通讯作者:Egbe, Alexander
Increased prevalence of left ventricular diastolic dysfunction in adults with repaired coarctation of aorta.
主动脉缩窄修复成人左心室舒张功能障碍的患病率增加。
- DOI:
- 发表时间:2020-06
- 期刊:
- 影响因子:0
- 作者:Egbe, Alexander C;Miranda, William R;Connolly, Heidi M
- 通讯作者:Connolly, Heidi M
Left Ventricular Remodeling After Transcatheter Versus Surgical Therapy in Adults With Coarctation of Aorta.
成人主动脉缩窄经导管与手术治疗后的左心室重塑。
- DOI:
- 发表时间:2020
- 期刊:
- 影响因子:0
- 作者:Egbe, Alexander C;Anderson, Jason H;Ammash, Naser M;Taggart, Nathaniel W
- 通讯作者:Taggart, Nathaniel W
Potential Benefits of Ambulatory Blood Pressure Monitoring in Coarctation of Aorta.
动态血压监测对主动脉缩窄的潜在益处。
- DOI:
- 发表时间:2020-04-28
- 期刊:
- 影响因子:24
- 作者:Egbe, Alexander C;Miranda, William R;Bonnichsen, Crystal R;Warnes, Carole A;Connolly, Heidi M
- 通讯作者:Connolly, Heidi M
Outcomes of Pregnancy in Patients With Prior Right Ventricular Outflow Interventions.
既往接受过右心室流出道干预的患者的妊娠结局。
- DOI:
- 发表时间:2019
- 期刊:
- 影响因子:5.4
- 作者:Egbe, Alexander C;El;Miranda, William R;Ammash, Naser M;Rose, Carl H;Fatola, Ayotola;Kothapalli, Srikanth;Abdelsamid, Mohamed Farouk;Connolly, Heidi M
- 通讯作者:Connolly, Heidi M
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Egbe其他文献
Alexander Egbe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Egbe', 18)}}的其他基金
Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta
血管紧张素II受体阻滞剂对主动脉缩窄修复患者心血管重塑的临床疗效及作用机制
- 批准号:
10734120 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiology
Fontan 生理学中肺血管扩张剂治疗的临床和血流动力学反应机制
- 批准号:
10542724 - 财政年份:2021
- 资助金额:
$ 17.33万 - 项目类别:
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot
法洛四联症心律失常和有氧能力受损的病理生理机制
- 批准号:
10661539 - 财政年份:2021
- 资助金额:
$ 17.33万 - 项目类别:
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot
法洛四联症心律失常和有氧能力受损的病理生理机制
- 批准号:
10458752 - 财政年份:2021
- 资助金额:
$ 17.33万 - 项目类别:
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot
法洛四联症心律失常和有氧能力受损的病理生理机制
- 批准号:
10268589 - 财政年份:2021
- 资助金额:
$ 17.33万 - 项目类别:
相似国自然基金
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms Underpinning Afterload-Induced Atrial Fibrillation
后负荷诱发心房颤动的机制
- 批准号:
10679796 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
可穿戴无线呼吸监测系统,可检测和预测阿片类药物引起的呼吸抑制
- 批准号:
10784983 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Developing Explainable AI for Equitable Risk Stratification of Atrial Fibrillation and Stroke
开发可解释的人工智能以实现心房颤动和中风的公平风险分层
- 批准号:
10752585 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Investigating structural and genetic substrates of early-onset atrial fibrillation
研究早发性房颤的结构和遗传基础
- 批准号:
10735490 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别:
Optimization of electromechanical monitoring of engineered heart tissues
工程心脏组织机电监测的优化
- 批准号:
10673513 - 财政年份:2023
- 资助金额:
$ 17.33万 - 项目类别: